As we discussed, central estrogen receptor signaling is necessary for GLP-1 to fully suppress food-reward behavior
To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist
Ozempic versus Mounjaro side effects
How long does it take to reach the full semaglutide dose
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a promising therapeutic option for promoting WL beyond lifestyle modifications, demonstrating efficacy in non-surgical populations [9, 10]